NOVAST is committed to achieving three major goals>>>

To launch high-barrier-entry prescription drugs into the US mainstream pharmaceutical market.

To use NOVAST's technical resources to introduce our pharmaceutical products with the same quality for US and China into Chinese market.

To promote progress of both China's high-barrier-entry pharmaceutical industry and price reduction of imported drugs to the benefit of Chinese consumers.

      NOVAST actively participates in the domestic and international

            dual cycle and is committed to serving for global health.